At baseline (week-33 to 36 of gestation), obese women with and without GDM had significantly increased levels of fasting insulin and C-peptide compared to lean subjects and showed increased insulin resistance estimated by HOMA-IR-index. The gene discussed is INS; the disease is Insulin resistance.